WHO selects Taiwan's Medigen COVID-19 vaccine for international trial
10/26/2021 10:46 PM
A COVID-19 vaccine developed by Taiwan's Medigen Vaccine Biologics Corp. has been chosen to take part in an international clinical trial platform co-launched by the World Health Organization (WHO), according to a statement released by the organization Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Tai, Sun carry flag for Team Taiwan at Paris Olympics opening ceremony
07/27/2024 08:23 AM - Society
Schools, offices in some towns, districts to close Saturday
07/26/2024 10:51 PM - Society
Magnitude 4.6 earthquake shakes Pingtung
07/26/2024 10:30 PM - Politics
Mayor, lawmaker convicted of corruption face different outcomes
07/26/2024 10:02 PM - Society
Typhoon Gaemi causes 8 deaths, 866 injuries as of Friday night
07/26/2024 09:58 PM